Argenica Therapeutics (ASX:AGN) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Argenica Therapeutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Argenica Therapeutics's Free Cash Flow for the six months ended in Dec. 2023 was A$-1.14 Mil. Argenica Therapeutics's Revenue for the six months ended in Dec. 2023 was A$0.00 Mil. Therefore, Argenica Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Argenica Therapeutics's current FCF Yield % is -5.31%.

The historical rank and industry rank for Argenica Therapeutics's FCF Margin % or its related term are showing as below:

ASX:AGN's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -143.16
* Ranked among companies with meaningful FCF Margin % only.

Argenica Therapeutics FCF Margin % Historical Data

The historical data trend for Argenica Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argenica Therapeutics FCF Margin % Chart

Argenica Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

FCF Margin %

Argenica Therapeutics Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
FCF Margin %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Argenica Therapeutics's FCF Margin %

For the Biotechnology subindustry, Argenica Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Argenica Therapeutics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Argenica Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Argenica Therapeutics's FCF Margin % falls into.

Argenica Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Argenica Therapeutics's FCF Margin for the fiscal year that ended in Jun. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2024 )	/	Revenue (A: Jun. 2024 )
	=	-5.061	/	0
	=	%

Argenica Therapeutics's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-1.137	/	0
	=	%

Argenica Therapeutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Argenica Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Argenica Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argenica Therapeutics Ltd (ASX:AGN) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

117 Broadway, Unit 4, Nedlands, WA, AUS, 6009

Website

https://www.argenica.com.au

Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.

Argenica Therapeutics Headlines

No Headlines